- Investing Ideas
- Swedish Pharmaceuticals & Biotech Most Popular Stocks
Swedish Pharmaceuticals & Biotech Most Popular Stocks
Results
90
Most Popular Stocks on the market
90 companies
Swedish Orphan Biovitrum
Market Cap: SEK 164.1b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 470.60
7D
2.9%
1Y
78.0%
Camurus
Market Cap: SEK 37.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 617.50
7D
0.2%
1Y
-7.7%
BioArctic
Market Cap: SEK 28.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 325.00
7D
5.0%
1Y
55.4%
AddLife
Market Cap: SEK 19.8b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 161.60
7D
2.6%
1Y
-4.7%
Bonesupport Holding
Market Cap: SEK 14.5b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 220.20
7D
8.0%
1Y
-31.9%
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.60
7D
0%
1Y
21.1%
Vitrolife
Market Cap: SEK 11.7b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 86.10
7D
1.1%
1Y
-39.0%
MedCap
Market Cap: SEK 8.3b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 548.50
7D
-1.4%
1Y
-16.1%
Swedencare
Market Cap: SEK 3.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 22.00
7D
-0.2%
1Y
-41.5%
Hansa Biopharma
Market Cap: SEK 3.5b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 34.40
7D
-12.7%
1Y
20.8%
Vicore Pharma Holding
Market Cap: SEK 3.1b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 11.12
7D
-0.9%
1Y
25.4%
Egetis Therapeutics
Market Cap: SEK 2.8b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 6.00
7D
-10.7%
1Y
11.7%
Saniona
Market Cap: SEK 1.9b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 14.23
7D
11.1%
1Y
55.7%
Flerie
Market Cap: SEK 1.8b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 20.50
7D
-1.4%
1Y
-45.8%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 22.95
7D
1.5%
1Y
-39.6%
Cereno Scientific
Market Cap: SEK 1.5b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 4.83
7D
-2.5%
1Y
-48.1%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.58
7D
-2.3%
1Y
-26.5%
Curasight
Market Cap: DKK 822.0m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 16.75
7D
-9.0%
1Y
394.1%
Medivir
Market Cap: SEK 1.2b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.82
7D
5.9%
1Y
-7.4%
Devyser Diagnostics
Market Cap: SEK 1.1b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 66.10
7D
6.3%
1Y
-55.0%
BICO Group
Market Cap: SEK 1.0b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 14.40
7D
7.6%
1Y
-60.0%
SynAct Pharma
Market Cap: SEK 997.9m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 18.26
7D
-1.2%
1Y
-13.0%
Infant Bacterial Therapeutics
Market Cap: SEK 883.7m
Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 67.00
7D
0.3%
1Y
32.7%
AlzeCure Pharma
Market Cap: SEK 868.8m
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 6.08
7D
-3.2%
1Y
94.2%
Xspray Pharma
Market Cap: SEK 789.0m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 16.88
7D
10.6%
1Y
-65.7%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%
Dicot Pharma
Market Cap: SEK 645.2m
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.18
7D
0.9%
1Y
-71.7%
Oncopeptides
Market Cap: SEK 626.1m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.58
7D
-1.3%
1Y
-72.5%
Cinclus Pharma Holding
Market Cap: SEK 552.9m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 11.96
7D
0.2%
1Y
-30.4%
FluoGuide
Market Cap: SEK 510.1m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 31.50
7D
-3.1%
1Y
-23.5%
Orexo
Market Cap: SEK 509.9m
A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 14.70
7D
-3.5%
1Y
-28.3%
Corline Biomedical
Market Cap: SEK 463.9m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 17.50
7D
-0.6%
1Y
35.7%
Enzymatica
Market Cap: SEK 458.8m
A life science company, develops and sells medical devices for infectious diseases.
ENZY
SEK 1.86
7D
-1.3%
1Y
-31.8%
Cantargia
Market Cap: SEK 451.5m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.82
7D
-1.0%
1Y
-43.7%
Moberg Pharma
Market Cap: SEK 445.6m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 9.45
7D
1.3%
1Y
4.9%
Mendus
Market Cap: SEK 441.7m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 6.94
7D
6.6%
1Y
-26.7%